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Purpose: Cationic liposomes (CLs) are composed of phospholipid bilayers. One of the most 
important applications of these particles is in drug and gene delivery. However, using CLs to 
deliver therapeutic nucleic acids and drugs to target organs has some problems, including low 
transfection efficiency in vivo. The aim of this study was to develop novel CLs containing 
magnetite to overcome the deficiencies.
Materials and methods: CLs and magnetic cationic liposomes (MCLs) were prepared using 
the freeze-dried empty liposome method. Luciferase-harboring vectors (pGL3) were transferred 
into liposomes and the transfection efficiencies were determined by luciferase assay. Firefly 
luciferase is one of most popular reporter genes often used to measure the efficiency of gene 
transfer in vivo and in vitro. Different formulations of liposomes have been used for delivery of 
different kinds of gene reporters. Lipoplex (liposome–plasmid DNA complexes) formation was 
monitored by gel retardation assay. Size and charge of lipoplexes were determined using particle 
size analysis. Chinese hamster ovary cells were transfected by lipoplexes (liposome-pGL3); 
transfection efficiency and gene expression level was evaluated by luciferase assay.
Results: High transfection efficiency of plasmid by CLs and novel nanomagnetic CLs 
was achieved. Moreover, lipoplexes showed less cytotoxicity than polyethyleneimine and 
Lipofectamine™.
Conclusion: Novel liposome compositions (1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
[DPPC]/dioctadecyldimethylammonium bromide [DOAB] and DPPC/cholesterol/DOAB) with 
high transfection efficiency can be useful in gene delivery in vitro. MCLs can also be used 
for targeted gene delivery, due to magnetic characteristic for conduction of genes or drugs to 
target organs.
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Introduction
Nanoliposomes are self-closed colloidal particles in which bilayered membrane(s) 
composed of self-aggregated lipid molecules make the vesicles. They encapsulate a 
fraction of the medium in which they are suspended into their interior.1
Liposomal vesicles have drawn the attention of researchers as potential carriers 
of various bioactive molecules that could be used for therapeutic applications in 
both humans and animals.2,3 Liposomes have been studied as models of biological 
membranes and more recently as carriers for the introduction of genes and drugs into 
target cells;1,4–7 thus, liposomes have been successful as carriers of antitumor drugs 
in cancer chemotherapy8 and for gene delivery purposes.9 Recent work has shown 
that nucleic acids can be entrapped in cationic liposomes (CLs) and subsequently 
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transfected into cultured mammalian cells, where they can 
express the information they carry.10 CLs represent one of 
the most widespread nonviral transfection systems for gene 
delivery.11 CLs are usually employed as a gene delivery 
system because of their low toxicity, low immunogenicity, 
ease of preparation,12 size-independent delivery of nucleic 
acids, and quality control and capacity for mass production 
at reasonable cost.13–15 Different methods for increasing 
liposome performance have been studied and have focused 
on the manufacturing of surface proteins or a combination 
of targeting ligands such as antibodies,16 transferin, and 
lactose. However, using CLs to deliver therapeutic nucleic 
acids and drugs to target organs has some problems, includ-
ing low transfection efficiency in vivo. With regard to this, 
novel CLs containing magnetite (MAG) were developed in 
this study to overcome the deficiencies. Magnetic cationic 
liposomes (MCLs) are prepared by incorporating MAG 
into CLs. MAG force-mediated gene delivery involves the 
use of a static magnetic field that guides magnetic particle-
associated gene vectors to accumulate on the cell surface.17 
High MAG concentration increases the size of CLs/plasmid 
DNA (pDNA) and MCLs/pDNA complex. The transfection 
efficiency of Chinese hamster ovary (CHO) cell line was 
investigated by using luciferase as a reporter.
On the other hand, genetically encoded imaging 
  reporters introduced into cells and transgenic animals 
enable noninvasive, longitudinal studies of dynamic biolog-
ical processes in vivo. The most common reporters include 
a firefly luciferase; the North American firefly Photinus 
pyralis luciferase, which emits yellow-green light, has been 
adapted for a variety of applications. Luciferase variants 
with red-shifted bioluminescence can be used alone for in 
vivo imaging. As transmission efficiency of light through 
tissue increases greatly for wavelengths above 600 nm, 
red-shifted firefly luciferase (λmax = 615 nm) could be suc-
cessfully employed as a sensitive reporter in mammalian 
cells. A number of point mutations have previously been 
identified that significantly produce red-emitting firefly 
luciferase.18
In this study, the freeze-dried empty liposome (FDEL) 
method19 was used to prepare different formulations of 
CLs and MCLs. The complex of liposome and plasmid 
(lipoplex) was formed in different solvents. A mutant pGL3 
plasmid with red-emitting P . pyralis luciferase gene with 
bioluminescence properties suitable for in vivo imaging 
was prepared. Size and charge of the lipolexes (CLs, MCLs, 
CLs/pDNA, MCLs/pDNA) were analyzed and related to 
transfection efficiency.
Materials and methods
Chemicals
The neutral lipid 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC) was purchased from Avanti Polar Lipids, Inc 
(Alabaster, AL). Cholesterol (Chol) was purchased from 
Sigma Aldrich (St Louis, MO). Dr Mahmoud Reza Jafari 
(Mashhad University of Medical Sciences, Mashad, Iran) 
kindly provided the dioctadecyldimethylammonium bromide 
(DOAB). Both D-luciferin potassium salt and adenosine-5′-
triphosphate (ATP) were obtained from SynChem, Inc (Elk 
Grove Village, IL). Both MTT 3(4,5dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide and magnetic nanoparticles 
(Fe3O4) were purchased from Sigma-Aldrich. All other 
chemicals were of commercial analytical grade and were used 
without further purification.
Production of red-emitting P. pyralis 
luciferase gene by site-directed 
mutagenesis
The QuikChange™ Site-Directed Mutagenesis Kit   (Stratagene, 
La Jolla, CA) was used to create red-emitting P . pyralis 
with conversion of S284 to T (S284T). The native gene 
had been cloned into a pGL3-control vector. The plasmids 
containing the mutant luciferase (S284T) were amplified 
using PrimeStar® DNA Polymerase (Takara Bio Inc, Otsu, 
Shiga, Japan) and two complementary primers containing 
the desired mutation, using a thermal cycler (PTC-1148, 
Bio-Rad, Singapore) (one cycle at 95°C; 20 cycles at 95°C 
for 1 minute, 55°C for 1 minute, and 68°C for 13 minutes; 
and a final extension for 10 minutes at 68°C). Subsequently, 
amplified products were purified using a clean-up kit   (Bioneer, 
Alameda, CA). The products were treated with DpnI to 
digest the non-mutated parental plasmids and were then 
transformed into competent Escherichia coli XL1-Blue cells. 
The primers and the corresponding reverse complements 
used were P . pyralis pGL3-control vector as a template and 
the primer set for S284T (where bold represents the mutated 
codon): 5′-CAGGATTACAAGATTCAAACTGCGCTGCT
GGTG-3′ (forward); 5′-CACCAGCAGCGCAGTTTGAAT
CTTGTAATCCTG-3 (reverse).
Preparation of CLs
Nanoliposomes were prepared in three formulations: 
(1) DPPC/Chol liposomes, (2) DPPC/DOAB liposomes, and 
(3) DPPC/Chol/DOAB liposomes.
The formulation for the DPPC/Chol liposomes was 
prepared by the FDEL method.19 The Chol and neutral lipid 
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(DPPC) powders were mixed at a molar ratio of 1:5 and 
were dissolved in the organic phase (chloroform). The chlo-
roform was evaporated using a rotary evaporator (Heidolph, 
Schwabach, Germany) under reduced pressure (temperature 
37°C, under vacuum, and 40 rpm) and lipid thin film was 
obtained. The lipid film was incubated at room temperature 
for 24 hours to form dried film. At the next step, distilled 
water at 50°C was added to the dried lipid film and vortex-
mixed vigorously for 30 minutes to obtain dispersion. Primary 
homogenization was performed by bath sonicator (Soltec, 
Milan, Italy) for 20 minutes and was then sonicated by 
microtip probe sonicators (Dr Hielscher, Teltow, Germany), 
at pulse on for 5.0 seconds and pulse off for 10.0 seconds, for 
3 minutes. The final step was lyophilization of homogeneous 
suspension by lyophilizer (VDH-2040, Snijders Scientific 
BV , Tilburg, The Netherlands). In this step, the suspension 
was frozen in liquid nitrogen, and then dried in a lyophilizer 
at −40°C and vacuum (0.4 millibars) condition. The product 
powder of vesicles was kept at −20°C until used.1,20
For the DPPC/DOAB liposomes, the DPPC and DOAB 
were mixed at a molar ratio of 1:1 and were dissolved in 
chloroform solution. The rest of the procedure was the same 
as for the DPPC/Chol liposomes.
For the DPPC/Chol/DOAB liposomes, the DPPC, Chol, 
and DOAB were mixed at a molar ratio of 7:2:1 and were 
dissolved in chloroform solution. The rest of the procedure 
was the same as for the DPPC/Chol liposomes.
Preparation of CL/pDNA complexes
Three methods were used for preparing liposomes to entrap 
plasmids: (1) suspension in water, (2) suspension in ethanol, 
and (3) suspension in plasmid aqueous buffer. In the first and 
second procedures, plasmids were mixed with liposomes in 
water or ethanol and pre-incubated at 4°C for 24 hours. The 
results of transfection efficiency by these liposomes were 
compared.
Preparation of MCL and MCL/pDNA  
complexes
DPPC, DOAB, and Chol were used as liposome components 
and MAG was used as the core. The DPPC, Chol, and DOAB, 
mixed at a molar ratio of 7:2:1, were dissolved in chloroform 
with different concentrations of MAG (0.5 and 1 mg/mL) in 
the presence of 5% dextrose solution 2.5 mL. The resulting 
suspension was emulsified by sonication. The organic phase 
was then evaporated at 25°C using a rotary evaporator under 
reduced pressure, and 5% dextrose solution 2.5 mL was added 
to the mixture of lipid and MAG colloid. The suspension was 
sonicated for 15 minutes and then centrifuged at 1000× g for 
15 minutes, to precipitate unincorporated MAG and retain 
the MCLs,21 which were then stored at 4°C. The MCL/
pDNA complex was prepared by mixing pDNA and MCL 
in various ratios in serum-free Dulbecco’s Modified Eagle 
Medium (DMEM; made from GIBCO® powder 12800-116 
[Stem Cell Technology Research Center, Royan Institute for 
Stem Cell Biology and Techology Iran]), and the mixture 
was incubated at room temperature for 45 minutes. This 
final composition was ready for performing transfection 
procedures according to a reported method.22
Determination of zeta potential, particle  
size, and polydispersity index of 
liposomes
Values of the zeta potential of liposomes indirectly reflect 
vesicle surface net charge and can therefore be used to 
evaluate the extent of interaction of the liposomal surface 
cationic charges with the anionic charges of DNA. The aver-
age particle size and the polydispersity of the particle-size 
distribution of the liposomes were determined by dynamic 
light scattering using photon correlation spectroscopy. The 
measurements were performed at 25°C using a Zetasizer 
Nano ZS instrument (Malvern Instruments Ltd, Malvern, 
Worcestershire, UK) equipped with a helium-neon laser and 
a scattering angle of 173°. Furthermore, the zeta potential of 
the liposome dispersions was also measured with the same 
instrument at 25°C by the electrophoretic mobility. All 
samples were not further diluted for each particle size and 
zeta potential measurement. A typical liposome refractive 
index of 1.45 was used.
gel retardation analysis of lipoplexes
Various formulations of liposome (DPPC/Chol, DPPC/
Chol/DOAB, and DPPC/DOAB) at 5:1, 7:2:1, and 1:1, 
respectively, molar ratios were mixed with DNA (0.5 mg) by 
three methods (suspension in water, suspension in ethanol, 
and suspension in plasmid aqueous buffer) at an N/P ratio of 
2.5 and then incubated at room temperature for 45 minutes. 
Lipoplexes were run on 0.7% agarose gel and were visual-
ized by ultraviolet illumination (uv-tech, Kiel, Germany) 
and electrophoretic mobility was investigated to evaluate the 
quantity of DNA entrapment. Empty liposomes and naked 
plasmid were used as controls.
Cell lines and culture
Chinese hamster ovarian cell line was a gift from Dr Baharvand 
(Royan Institute, Tehran, Iran). CHO cells were cultured in 
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high-glucose DMEM supplemented with 10% fetal bovine 
serum (FBS) (GIBCO®EU 10270), penicillin 100 U/mL and 
streptomycin 100 µg/mL in a humidified atmosphere of 5% 
CO2 and 37°C. Cells were seeded in a 24-well cell culture 
plate 1 day before transfection.23
Cell viability assay
CHO cells were seeded in 96-well plates and incubated for 
24 hours. Cells were attached to the plate surface and were then 
treated with CLs and MCLs at the same concentrations used for 
transfection experiments. Moreover, polyethyleneimine (PEI) 
0.6 µL (1.9 µg/mL) and Lipofectamine 1.0 µL (1 mg/mL) per 
well were used. Cell viability was assayed using MTT accord-
ing to a reported method24 with minor modifications. Briefly, 
MTT 10 µL (5 mg/mL) was added to each well and the cells 
were incubated at 37°C for 4 hours. The formazan product was 
dissolved in 10% sodium dodecyl sulfate 100 µL containing 
hydrochloric acid 15 mM.25 Color intensity was measured 
using an absorbance microplate reader (ELx800™, BioTek, 
Winooski, VT) at test and reference wavelengths of 570 nm.
In vitro transfection experiment
One day before transfection, CHO cells were seeded in 
24-well sterile culture plates at a density of 2 × 105 cells/well 
and were grown overnight to approximately 80%   confluence. 
For transfection, the growth medium was removed 
and then cells were washed twice with pre-warmed 
phosphate-buffered saline (PBS). The complexes with three 
different combinations of liposomes (DPPC/Chol, DPPC/
DOAB, and DPPC/Chol/DOAB, with an N/P ratio of 2.5), 
and Lipofectamine™ and PEI as controls, were, in serum-
free DMEM, added to the cells (pDNA 0.5 µg/well) and 
the cells were then incubated for 6 hours. In addition, the 
complexes with different N/P ratios (2.5 and 5) and two 
different MAG concentrations (0.5 and 1 mg/mL) were, in 
serum-free DMEM, added to the wells (pDNA 0.5 µg/well) 
and the cells were incubated for 4 and 6 hours. After 
transfection, the incubation medium was replaced with 
DMEM supplemented with 10% FBS and incubated for 
another 24 hours (in a humidified atmosphere of 5% CO2 
and 37°C) prior to evaluation of transfection efficiency using 
luciferase assay. In the case of magnetic induction MCLs/
pDNA lipoplexes and CLs/pDNA complexes, a permanent 
magnet of strength 0.3 T was placed under the cell culture 
plate. The magnet was removed at 30 and 60 minutes after 
addition of transfection suspension (MCLs/pDNA lipoplexes 
and CLs/pDNA complexes) and the incubation continued for 
4 and 6 hours. To analyze luciferase activity, the transfected 
cells in each well were washed twice gently with PBS 3 mL 
and the cells were lysed with cell culture lysis buffer 100 µL 
(Promega Corporation, Madison, WI). The luciferase activity 
in each sample was indicated as the relative light unit in pres-
ence of luciferin, ATP, and magnesium2+ as the substrates of 
luciferase with a luminometer (Berthold Detection Systems 
GmbH, Pforzheim, Germany).
Results and discussion
Zeta potential, particle size, and 
polydispersity index of liposomes
Many physicochemical factors influence CL transfection 
efficiency including the charge of CLs, the size of the com-
plexes, and the total lipid/pDNA ratio. These parameters 
can affect stability and reproducibility of used liposomes in 
transfection.26 Since the use of magnetic particles changes 
the charge and size of CLs, the amount of MAG incorporated 
into liposomes should be low enough to not cause a drastic 
change in charge and size and high enough to respond to 
an external magnetic field.27 The mean particle size and 
zeta potential (surface charge potential) of MCLs with two 
different concentrations of MAG (0.5 and 1.0 mg/mL) and 
CLs were measured. As seen in Table 1, the average size 
of particles in MCLs and MCLs/pDNA was higher than in 
CLs and CLs/pDNA complexes. The MCLs with a lower 
concentration of MAG (0.5 mg/mL) were smaller than those 
with higher concentration (1.0 mg/mL). On the other hand, 
Table 1 The mean particle size and zeta potential of cationic liposomes (CLs) and magnetic cationic liposomes (MCLs) with two 
different concentrations of magnetite (MAg; 0.5 and 1 mg/mL) and their complexes with plasmid DNA (pDNA)
Group Sample Mean particle size (nm) pdl Zeta potential (mV)
1 CLs 72.82 0.2 +46
2 MCLs (MAg 0.5 mg/mL) 86.63 0.2 +44.1
3 MCLs (MAg 1 mg/mL) 295.7 0.3 +51.9
4 CLs/pDNA complexes 135 0.3 +20
5 MCLs/pDNA complexes (MAg 0.5 mg/mL) 132.7 0.2 +17.2
6 MCLs/pDNA complexes (MAg 1 mg/mL) 372.5 0.2 +33.5
Abbreviation: pdl, polydispersity index.
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the increasing average particle size of MCLs/pDNA and 
CLs/pDNA compared with MCLs and CLs could be due to 
adhesion and fusion of plasmid to liposomes.28 Zeta potential 
of MCLs and MCLs/pDNA decreased significantly compared 
with CLs and CLs/pDNA. The addition of MAG 0.5 mg/mL 
resulted in the highest decrease in zeta potential of MCLs 
and MCLs/pDNA complexes compared with those without 
MAG (CLs and CLs/pDNA complexes). The zeta potential 
of liposomes and complexes containing MAG 0.5 mg/mL 
was not significantly different from the zeta potential of those 
containing MAG 1.0 mg/mL. Therefore, it may be suggested 
that MAG interaction with the cationic polar head groups 
of the bilayer in CLs neutralize some of the positive surface 
charge characteristics through charge shielding.
gel retardation analysis of lipoplexes
Three types of CLs with different molar ratios (DPPC/Chol, 
5:1; DPPC/DOAB, 1:1; DPPC/Chol/DOAB, 7:2:1) were 
prepared. Lipoplexes of these compositions were prepared by 
three methods (suspension in water, suspension in ethanol, and 
suspension in plasmid aqueous buffer). Gel retardation analysis 
of lipoplexes showed the ability of different formulations of 
liposome to entrap pDNA. With the first composition (DPPC/
Chol; molar ratio 5:1), it seemed that because of the absence 
of cationic lipid with a positive charge, they had no ability to 
entrap plasmid and thus the plasmid moved through the gel 
(Figure 1A). With the second liposome composition (DPPC/
DOAB; molar ratio 1:1) having cationic lipid, DNA retarda-
tion suggested interaction between negatively charge DNA 
and CLs (Figure 1B). In this case, preparation of liposomes 
using an aqueous solution of plasmid could not entrap the 
plasmid, as observed in the third lane. It seems that suspend-
ing of liposome powder 1 day before mixing with pDNA and 
formation of lipoplexes is necessary for pDNA entrapment. 
The third complex (DPPC/Chol/DOAB; molar ratio 7:2:1), 
which comprised a neutral phospholipid, Chol, and a cationic 
lipid, was prepared with all three methods (water, ethanol, 
aqueous solution of plasmid) (Figure 1C) and was found to be 
efficient in DNA entrapment except in the aqueous solution 
of plasmid sample. The MCLs/pDNA lipoplex (DPPC/Chol/
DOAB; molar ratio 7:2:1) in two concentrations of MAG (0.5 
and 1 mg/mL) was examined (Figure 1D). This combination 
was also found to be effective in DNA entrapment, presumably 
because of the presence of cationic lipids.
Optimization of CLs composition
Liposomes with composition of DPPC/Chol/DOAB at 
molar ratios of 7:2:1, 5:2:1, and 7:4:1 were prepared in 
water suspension. The transfection efficiencies of these 
three compounds were compared. Results of enzymatic 
assay indicated that transfection efficiency was highest in 
liposomes that contain a higher ratio of cationic lipid to the 
total lipid content (CL/TL) of liposomes (DPPC/Chol/DOAB 
at a molar ratio of 5:2:1 with CL/TL = 1:8, in comparison 
with similar liposome composition at a molar ratio of 7:2:1 
with CL/TL = 1:10, and similar liposome composition at a 
molar ratio of 7:4:1 with CL/TL = 1:12). So with decrease in 
ratio of CL/TL content of liposomes, reduction of transfection 
efficiency was observed (Figure 2).
In addition, preparation of other liposomes with DPPC/
DOAB at a molar ratio of 1:1 and 3:1 in water suspension 
was compared. Similarly, enzymatic assay indicated that 
transfection efficiency was higher in liposomes containing 
a higher ratio of cationic lipid to the total lipid structure of 
liposomes (Figure 2).
However, based on a simple comparison of transfection 
efficiencies between two liposome preparations (DPPC/
DOAB and DPPC/Chol/DOAB), the authors expected 
AB
CD
Ladder
Liposome
pGL3
12 3
Ladder
Liposome
pGL3
123
Ladder
Liposome
pGL3
1 mg/mL magnetite
0.5 mg/mL magnetite
Liposome
pGL3
Ladder
123
Figure  1  gel  retardation  of  (A)  1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC)/cholesterol  (Chol)  at  a  molar  ratio  of  5:1  lipoplex;  (B)  DPPC/
dioctadecyldimethylammonium bromide (DOAB) at a molar ratio of 1:1 lipoplex; 
(C) DPPC/Chol/ DOAB at a molar ratio of 7:2:1 lipoplex; (D) magnetic cationic 
liposomes/pDNA with different concentrations of magnetite (MAg). pgL3 plasmid 
and empty liposomes were used as controls. For all panels, (1) is suspension in water, 
(2) is suspension in ethanol, and (3) is suspension in aqueous solution of plasmid.
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higher transfection efficiency of DPPC/DOAB than DPPC/
Chol/DOAB because of a higher ratio of CL/TL (1:2, 1:4 
for DPPC/DOAB, respectively; 1:8,1:10,1:12 for DPPC/
Chol/DOAB, respectively). Because of the important role 
of Chol in the formation and stability of the liposomal 
membrane and because more types of lipids participated 
in DPPC/Chol/DOAB liposomes than in DPPC/DOAB 
liposomes, the transfection efficiency of DPPC/Chol/
DOAB was higher. Similar results have been reported in 
previous studies.20
Three preparation methods (suspension in ethanol, 
suspension in water, and suspension in plasmid aqueous 
buffer) were used before plasmid entrapment. Preparation 
in water and ethanol was accompanied with full loading 
of pDNA, while suspension in plasmid aqueous buffer did 
not bring any entrapment (Figure 1B and C). Suspension in 
ethanol had higher transfection efficiency than suspension 
in water (Figure 3); therefore, it may be surmised that higher 
transfection efficiency in ethanol was due to the presence 
of ethanol. The positive effect of ethanol on lipid-mediated 
transfection has been reported previously.29
Transfection efficiencies of CLs with 
different compositions
CHO cells were transfected with DPPC/DOAB (molar ratio 
1:1) and DPPC/Chol/DOAB (molar ratio 7:2:1) and different 
preparation methods were compared. The luciferase activity 
of cell extracts, as the indicator of transfection efficiency, was 
determined. As indicated in Figure 3, the highest transfec-
tion efficiency was obtained for liposomes with DPP/Chol/
DOAB composition in ethanol suspension at a molar ratio 
of 7:2:1.
Optimization of MCLs/pDNA N/P ratio
The effects of different concentrations of MAG (0.5 and 
1.0 mg/mL) and different ratios of pDNA and MCLs (N/P 
ratio) on transfection efficiency were studied. The incubation 
time for transfection was 6 hours. Higher luciferase activity 
(highest transfection efficiency) was obtained for MCLs/
pDNA (N/P = 5) with MAG concentration of 0.5 mg/mL 
(Figure 4).
Optimization of incubation time
The effects of incubation time on transfection efficiency of 
MCLs with two MAG concentrations (0.5 and 1.0 mg/mL) 
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Figure 2 Comparing the transfection efficiencies of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC)/cholesterol (Chol)/dioctadecyldimethylammonium bromide 
(DOAB) and DPPC/DOAB liposomes with different molar ratios. 
Abbreviation: RLU, relative light unit.
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Figure 3 Comparison of luciferase assay in cells transfected by 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC)/cholesterol (Chol)/dioctadecyldimethylammonium 
bromide (DOAB) liposomes composition at a molar ratio of 7:2:1 and DPPC/DOAB 
at a molar ratio of 1:1, and comparison of different methods of preparing them. 
Abbreviation: RLU, relative light unit.
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Figure  4  Optimizing  the  magnetic  cationic  liposome  (MCL)/plasmid  DNA 
(pDNA) N/P ratio evaluated by luciferase assay in Chinese hamster ovary cells. 
Abbreviation: RLU, relative light unit.
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and its effect on transfection efficiency of MCLs/pDNA 
lipoplexes with the optimal combination ratio were 
  investigated. For MCLs/pDNA lipoplex in which the 
MCL MAG concentration was 0.5 mg/mL, maximal 
luciferase activity was shown at 6 hours’ incubation time 
(Figure 5). As indicated in Figure 6, sufficient transfec-
tion was observed upon 4 hours’ incubation with MCLs, 
an effect that was not observed for CLs. Therefore, the 
optimum time of liposome incubation was reduced in the 
presence of MCLs.
Transfection efficiency of MCLs
Many factors influence the transfection efficiency of CLs, 
including type of cell transfected, pDNA/CLs ratio, lipo-
some concentration, and incubation time.30 Long incuba-
tion time may increase the cytotoxicity of liposome, so 
optimization of CLs/plasmid ratio and also reducing the 
incubation time could improve conditions of transfection 
by CLs. Using MCLs and an external magnetic field can 
decrease cytotoxicity, because of reduced incubation time. 
The MCLs/pDNA with MAG 0.5 mg/mL complex was 
more effective in transfection because of its smaller size 
and lower zeta potential compare with MCLs/pDNA with 
MAG 1.0 mg/mL complex (Figure 4).
Comparison of transfection efficiency 
under optimal transfection conditions  
in CHO cells
Transfection efficiency of lipoplexes including CLs/pDNA 
and MCLs/pDNA (with two different concentrations of 
MAG) was compared by luciferase assay using the optimal 
N/P ratio and incubation time (Figure 6). The luciferase 
activity in the transfected cells by CLs/pDNA lipoplex and 
MCLs/pDNA lipoplex with MCLs with MAG 0.5 mg/mL 
concentration was similar, while with MCLs with MAG 
1.0 mg/mL concentration, the luciferase activity was lower. 
This result was in agreement with a reported result that 
indicates transfection efficiency of MCLs (MAG 0.5 mg/mL) 
was similar to that of CLs in the absence of a magnetic field.31 
The relatively lower gene transfection efficiency of MCLs/
pDNA lipoplex with higher MAG content (1.0 mg/mL) may 
be due to the extra cellular toxicity32 and to increasing the 
size of particle (Table 1).
Enhanced transfection efficiency of 
MCLs/pDNA complexes by magnetic 
induction
After optimizing the transfection condition, the effects of 
magnetic field exposure times (30 and 60 minutes) followed by 
different incubation times (4 and 6 hours) on the transfection 
efficiency were studied. Magnetic field exposure was applied at 
different times on transfected cells by MCLs (MAG 0.5 mg/mL). 
Longer magnetic field exposure times for transfected cells 
after 6 hours resulted in a decrease of luciferase activity, 
while after 4 hours luciferase activity (transfection efficiency) 
increased with longer exposure times (60 minutes) (Figure 7). 
The mechanism of MCLs/DNA lipoplex uptake into cells 
was possibly the as same as for CLs/DNA lipoplex, which 
was compatible with the comparable transfection activity of 
CLs/pDNA and MCLs/pDNA lipoplexes without magnetic 
induction. Magnetic nanoparticles are co-internalized with 
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Figure 5 Optimization of incubation time evaluated by luciferase assay in Chinese 
hamster ovary cells with magnetic induction. 
Abbreviations: MCL, magnetic cationic liposome; RLU, relative light unit.
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vectors into cells.33 Magnetic interaction between applied 
magnetic fields and magnetic nanoparticles could accelerate 
  accumulation of the complexes on the surface of the cells. 
Then   during the intracellular   processing nanoparticles at a 
certain concentration may probably interact with the cell mem-
brane, which could result in the nonspecific changes of mem-
brane properties (such as ion transport potential and possibly 
fluidity) or destabilization of the endosomal environment.34 
These could contribute to the rapid and effective gene delivery 
under a magnetic field. Therefore, it may be concluded that 
higher transfection efficiencies may arise from magnetic 
nanoparticle interaction with the cell membrane.
Cell viability assay
One of the most important aspects of transfection reagents is 
their toxicity. The cytotoxic effect of different concentrations 
of MCLs, CLs, PEI, and Lipofectamine on surviving CHO 
cells was investigated. Lower toxic effects on CHO cell viabil-
ity were observed for CLs and MCLs (MAG 0.5 and 1.0 mg/
mL), while a major reduction in viable cells was observed 
for PEI treatment. The percentage of survival after exposure 
to CLs (90%), MCLs (MAG 0.5 mg/mL, 85%), and MCLs 
(MAG 1.0 mg/mL, 84%) were observed. In comparison with 
PEI (15%) and Lipofectamine (70%), a less cytotoxic effect 
with our lipoplex preparations was observed (Figure 8).
Conclusion
Based on the results presented here, the authors conclude 
that the liposome compositions (DPPC/DOAB and DPPC/
Chol/DOAB) prepared with high transfection efficiency 
may be useful in gene delivery in vitro. For the first time, 
using magnetic nanoparticles in these compositions brought 
about suitable transfection efficiency, although a reduction in 
cytotoxicity due to reduced incubation time was observed. 
An increase in concentrations of MAG incorporated into 
the liposomes and complexes in turn increases the particle 
size of MCLs and MCLs/pDNA complexes. MCLs/pDNA 
can respond to an external magnetic field and this quality 
is effective in conducting MCLs to the desired tissue in 
gene delivery and in reducing side effects in drug delivery 
systems. Moreover, transfection efficiency of a red-emitter 
mutant (S284T) pGL3 by different liposome composition was 
investigated. Results showed the mutant gene with red-emitting 
luciferase activity is transfected efficiently by different 
vehicle. Therefore, it may be suggested, this plasmid vector 
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Figure 7 Effect of magnetic field exposure on transfection efficiency. (A) magnetic 
cationic liposomes (MCLs)/plasmid DNA (pDNA) lipoplex (MCLs with magnetite 
[MAg] 0.5 mg/mL concentration) after 6 hours’ incubation and (B) MCLs/pDNA 
lipoplex (MCLs with MAg 0.5 mg/mL concentration) after 4 hours’ incubation. 
These experiments were carried out under the optimal transfection conditions and 
magnetic induction time was varied from 30 to 60 minutes. 
Abbreviation: RLU, relative light unit.
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Figure 8 Viability of Chinese hamster ovary cells treated with cationic liposomes 
(CLs),  magnetic  cationic  liposomes  (MCLs),  polyethyleneimine  (PEI),  and 
Lipofectamine™. Cells were seeded at 105 cells/mL in a 96-well plate and incubated 
at 37°C. Percentage of cell viability was determined following 24-hour exposure to 
varying amounts of MCLs (0.5 and 1 mg/mL of magnetite). 
Note: Data represents the percentage of cell viability compared with untreated 
cells and cells treated with Lipofectamine and PEI as controls.
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with red-emitter luciferase can be suitable for in vivo studies. 
In an overview the MCLs may be considered in gene delivery 
systems for conducting them to the target tissue in vivo.
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